Home › Funds › LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA › ISRG

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA position in ISRG

INTUITIVE SURGICAL INC · Health Care

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reported holding 138,050 shares of ISRG (INTUITIVE SURGICAL INC) in its Q3 2026 13F filing — a position valued at US$56.1M, representing 0.52% of its reported portfolio and ranking #44 among its reported holdings. LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed ISRG holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)138.05K sh
Reported value held$56.14M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's ISRG position evolved

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA first disclosed a stake in ISRG in Q3 2023 at 8,872 shares (US$2.5M). The position peaked in Q3 2026 at 138,050 shares, worth US$56.1M. Across 13 filings, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 138,050 shares valued at US$56.1M — an increase of 96,938 shares quarter over quarter.. Notable position changes include a 35% increase in Q3 2025 (shares rose 27% over the following quarter), a 491% increase in Q2 2026 (shares rose 2% over the following quarter), a 236% increase in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.87K $2.47M New
Q4 2023 8.90K $3.37M Hold
Q1 2024 8.92K $3.29M Hold
Q2 2024 8.92K $3.91M Hold
Q3 2024 7.68K $3.93M Reduce
Q4 2024 7.68K $4.41M Hold
Q1 2025 6.90K $3.37M Reduce
Q2 2025 6.90K $3.75M Hold
Q3 2025 9.34K $5.15M Add
Q4 2025 7.00K $3.68M Reduce
Q1 2026 6.96K $3.13M Reduce
Q2 2026 41.11K $16.35M Add
Q3 2026 138.05K $56.14M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ISRG and 13F data

ISRG (INTUITIVE SURGICAL INC) is a Health Care company. 26 other funds we track also report a position in ISRG — the largest reported positions include Invesco Ltd (US$4.89B), PRICE T ROWE ASSOCIATES INC /MD/ (US$4.48B), ALLIANCEBERNSTEIN L.P. (US$1.67B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ISRG

All ISRG fund holders →

FAQ

How long has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA held ISRG?

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed ISRG holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's current position in ISRG?

As of Q3 2026, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 138.05K shares of ISRG (INTUITIVE SURGICAL INC), valued at $56.14M, representing 0.52% of its reported portfolio and ranking #44.

Has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA been buying or selling ISRG?

In the latest 13F filing (Q3 2026), LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA increased its position in ISRG. The position peaked in Q3 2026 at 138.05K shares.

Which other funds hold ISRG?

Other major institutional holders of ISRG include Invesco Ltd, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.